BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Y, Su W, Zhu Z, Tang L, Hu X, Zhou S, Fang Z, Li J. Elevated serum HMGB1 in pulmonary arterial hypertension secondary to congenital heart disease. Vascular Pharmacology 2016;85:66-72. [DOI: 10.1016/j.vph.2016.08.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Goldenberg NM, Rabinovitch M, Steinberg BE. Inflammatory Basis of Pulmonary Arterial Hypertension: Implications for Perioperative and Critical Care Medicine. Anesthesiology 2019;131:898-907. [PMID: 31094755 DOI: 10.1097/ALN.0000000000002740] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
2 VanPatten S, Al-Abed Y. High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target. J Med Chem. 2018;61:5093-5107. [PMID: 29268019 DOI: 10.1021/acs.jmedchem.7b01136] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
3 Peek V, Harden LM, Damm J, Aslani F, Leisengang S, Roth J, Gerstberger R, Meurer M, von Köckritz-Blickwede M, Schulz S, Spengler B, Rummel C. LPS Primes Brain Responsiveness to High Mobility Group Box-1 Protein. Pharmaceuticals (Basel) 2021;14:558. [PMID: 34208101 DOI: 10.3390/ph14060558] [Reference Citation Analysis]
4 Feng W, Wang J, Yan X, Zhang Q, Chai L, Wang Q, Shi W, Chen Y, Liu J, Qu Z, Li S, Xie X, Li M. ERK/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension. Cell Prolif 2021;54:e13048. [PMID: 33948998 DOI: 10.1111/cpr.13048] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Wahid A, Chen W, Wang X, Tang X. High-mobility group box 1 serves as an inflammation driver of cardiovascular disease. Biomed Pharmacother 2021;139:111555. [PMID: 33865014 DOI: 10.1016/j.biopha.2021.111555] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Uk Kang T, Park KY, Kim HJ, Ahn HS, Yim S, Jun J. Association of hyperuricemia and pulmonary hypertension: A systematic review and meta-analysis. Modern Rheumatology 2019;29:1031-41. [DOI: 10.1080/14397595.2018.1537555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dai M, Xiao R, Cai L, Ge T, Zhu L, Hu Q. HMGB1 is mechanistically essential in the development of experimental pulmonary hypertension. Am J Physiol Cell Physiol 2019;316:C175-85. [PMID: 30517029 DOI: 10.1152/ajpcell.00148.2018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Li FJ, Zhang CL, Luo XJ, Peng J, Yang TL. Involvement of the MiR-181b-5p/HMGB1 Pathway in Ang II-induced Phenotypic Transformation of Smooth Muscle Cells in Hypertension. Aging Dis 2019;10:231-48. [PMID: 31011475 DOI: 10.14336/AD.2018.0510] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
9 Wadie W, Abdel-Razek NS, Salem HA. Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats. Life Sci 2021;277:119506. [PMID: 33865881 DOI: 10.1016/j.lfs.2021.119506] [Reference Citation Analysis]
10 Chen J, Rathinasabapathy A, Luo J, Yang X, Luo P, Chen Y, Li Z, Li J. Differential serum lipid distribution in IPAH and CHD-PAH patients. Respir Med 2021;191:106711. [PMID: 34890866 DOI: 10.1016/j.rmed.2021.106711] [Reference Citation Analysis]
11 Fan J, Qiu Y, Zheng Z, Yu L, Shi S, Wu X. NOD-like receptor protein 3 and high mobility group box-1 are associated with prognosis of patients with congenital heart disease. J Int Med Res 2020;48:300060519884500. [PMID: 31852352 DOI: 10.1177/0300060519884500] [Reference Citation Analysis]
12 Clavé MM, Maeda NY, Thomaz AM, Bydlowski SP, Lopes AA. Phosphodiesterase type 5 inhibitors improve microvascular dysfunction markers in pulmonary arterial hypertension associated with congenital heart disease. Congenit Heart Dis 2019;14:246-55. [PMID: 30343508 DOI: 10.1111/chd.12688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Chen C, Luo F, Wu P, Huang Y, Das A, Chen S, Chen J, Hu X, Li F, Fang Z, Zhou S. Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China. J Cell Mol Med 2020;24:2484-96. [PMID: 31945804 DOI: 10.1111/jcmm.14937] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
14 Zhang L, Qi X, Zhang G, Zhang Y, Tian J. Saxagliptin protects against hypoxia-induced damage in H9c2 cells. Chem Biol Interact 2020;315:108864. [PMID: 31629700 DOI: 10.1016/j.cbi.2019.108864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bomfim GF, Rodrigues FL, Carneiro FS. Are the innate and adaptive immune systems setting hypertension on fire? Pharmacol Res 2017;117:377-93. [PMID: 28093357 DOI: 10.1016/j.phrs.2017.01.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]